Skip to main content

Featured

RMB stock trading backed

Secretary for Financial Services & the Treasury Christopher Hui today expressed his gratitude to various listed issuers in Hong Kong for their support to the proposal of setting up a renminbi (RMB) stock trading counter.   Mr Hui stated that further to the help rendered by the Legislative Council Panel on Financial Affairs regarding the Government's proposed measures to promote the issuance and trading of RMB stocks in Hong Kong and enhance the trading mechanism, a number of listed issuers have also backed the proposal.   Such listed issuers will actively explore the feasibility of setting up a new RMB trading counter for their issued shares.   Mr Hui explained that listed issuers who indicated their support today include Hang Seng Index constituent stocks with promising turnover.   “Their participation is a vote of confidence to the development of RMB securities in Hong Kong, which will be conducive to our promotion work to other issuers, enabling Hong Kong to graduall

Vaccination cases assessed

The Expert Committee on Clinical Events Assessment Following COVID-19 Immunisation assessed four death cases with history of vaccination during its meeting today.   Between April 5 and 18, the Department of Health received four death reports with history of COVID-19 immunisation from the Hospital Authority (HA).   The cases involve four men aged between 54 and 92. Based on the preliminary autopsy findings, the committee considered there was no evidence to indicate an association between the deceased's outcome and vaccination.   The first case involved a 92-year-old man who had hypertension, ischaemic heart disease, atrial flutter, ischaemic stroke, hyperlipidaemia and renal impairment.   He passed away on April 5 and had received a dose of Sinovac 18 days before his death.   Based on the preliminary autopsy findings, the death was due to left haemothorax and ruptured dissecting aneurysm of the aorta.   The second case involved a 58-year-old man who was a chronic smoker. He passed away on April 8 and had received a dose of Sinovac 23 days before his death. The autopsy findings revealed that he died of coronary artery disease.    The third case involved a 72-year-old man who had a history of chronic renal failure and was on regular haemodialysis. During a haemodialysis hospital visit on April 16, he suddenly went into cardiac arrest and passed away.    He received a dose of Sinovac 23 days before his death. Provisional causes of death were haemodialysis catheter related sepsis and hyperkalaemia.   The last case involved a 54-year-old man who was a smoker. He passed away on April 18 and he received a dose of Sinovac 16 days before his death.   Based on the preliminary autopsy findings of hypertensive heart disease, the committee considered that there was no evidence indicating an association between the deceased's outcome and vaccination, adding that a full autopsy report was required in order to conclude the causality assessment.   In addition, the committee conducted a causality assessment of two pregnant women. Both aged 32, they received treatment in the HA due to miscarriage and fetal death.    After reviewing the relevant clinical information and pathology results, the committee concluded that there was no evidence indicating an association with vaccination and noted that the concerned hospital would further investigate the cause of the fetal death.
http://dlvr.it/Ry8RPR

Popular Posts